Centiva Capital, LP Insmed Inc Transaction History

Centiva Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$16.44 - $21.1 $158,629 - $203,593	9,649 New	9,649 $203,000
Q2 2021 Aug 16, 2021	SELL	$24.17 - $36.01 $220,792 - $328,951	-9,135 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$32.28 - $44.3 $100,100 - $137,374	3,101 Added 51.39%	9,135 $311,000
Q4 2020 Feb 16, 2021	BUY	$31.45 - $40.54 $189,769 - $244,618	6,034 New	6,034 $201,000

484

182M

2.14M

3.25M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.6B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.